Matches in Wikidata for { <http://www.wikidata.org/entity/Q70539241> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q70539241 description "article scientifique publié en 1993" @default.
- Q70539241 description "artikull shkencor i botuar më 01 shkurt 1993" @default.
- Q70539241 description "artículu científicu espublizáu en febreru de 1993" @default.
- Q70539241 description "im Februar 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70539241 description "scientific article published on 01 February 1993" @default.
- Q70539241 description "wetenschappelijk artikel" @default.
- Q70539241 description "наукова стаття, опублікована в лютому 1993" @default.
- Q70539241 name "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 name "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 name "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 type Item @default.
- Q70539241 label "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 label "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 label "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 prefLabel "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 prefLabel "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 prefLabel "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 P1433 Q70539241-49BAF5CD-361C-443F-9600-5FAD640627B8 @default.
- Q70539241 P1476 Q70539241-724A45BB-D72D-4904-9CE1-A29491C3E3B0 @default.
- Q70539241 P2093 Q70539241-18A2BAF7-199C-46C8-A35D-DD84E2BA15BD @default.
- Q70539241 P2093 Q70539241-66B899CF-9123-4B95-8966-B547AA152B70 @default.
- Q70539241 P2093 Q70539241-8E4673DF-2188-4E87-9941-24E032392482 @default.
- Q70539241 P2093 Q70539241-A06F2093-8A35-4EEB-B279-CA94C3BD95B9 @default.
- Q70539241 P2093 Q70539241-B14AAAE2-7CC5-4E55-8C5C-89C97049D001 @default.
- Q70539241 P2093 Q70539241-E9617F02-014E-4E8D-B07C-32272EBE61FA @default.
- Q70539241 P304 Q70539241-8950D50E-7129-4B77-B427-BBC312671236 @default.
- Q70539241 P31 Q70539241-9BC505F6-6BC3-4371-B6AF-95095CA843B0 @default.
- Q70539241 P356 Q70539241-5C387628-7021-4756-9D1B-B7C4AF26EE27 @default.
- Q70539241 P433 Q70539241-A7D49A5E-4AD3-4F45-82EA-739FCE75D092 @default.
- Q70539241 P478 Q70539241-9C6AB374-CC54-4A73-8D42-22DAC4E6E743 @default.
- Q70539241 P577 Q70539241-ACDA3FEA-7643-49BF-BBB3-8EED129CA4D6 @default.
- Q70539241 P698 Q70539241-20FC0212-F564-4F34-B62C-72B4565E3B73 @default.
- Q70539241 P921 Q70539241-80644FD1-E1E6-454E-9C13-0DB0A6E90560 @default.
- Q70539241 P356 00000421-199302000-00019 @default.
- Q70539241 P698 8424410 @default.
- Q70539241 P1433 Q2886177 @default.
- Q70539241 P1476 "Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2" @default.
- Q70539241 P2093 "K M Pisters" @default.
- Q70539241 P2093 "L B Tyson" @default.
- Q70539241 P2093 "M G Kris" @default.
- Q70539241 P2093 "R A Clark" @default.
- Q70539241 P2093 "R J Gralla" @default.
- Q70539241 P2093 "W F Hahne" @default.
- Q70539241 P304 "77-80" @default.
- Q70539241 P31 Q13442814 @default.
- Q70539241 P356 "10.1097/00000421-199302000-00019" @default.
- Q70539241 P433 "1" @default.
- Q70539241 P478 "16" @default.
- Q70539241 P577 "1993-02-01T00:00:00Z" @default.
- Q70539241 P698 "8424410" @default.
- Q70539241 P921 Q42824440 @default.